Atherton Lane Advisers’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Atherton Lane Advisers’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$225K	Hold	3,210	–	–	0.01%	210
2015 Q3	$213K	Hold	3,210	–	–	0.01%	213
2015 Q2	$251K	Hold	3,210	–	–	0.01%	207
2015 Q1	$245K	Hold	3,210	–	–	0.01%	235
2014 Q4	$214K	Hold	3,210	–	–	0.01%	254
2014 Q3	$204K	Buy	+3,210	New	+$198K	0.01%	259

Other funds holding PJP

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Atherton Lane Advisers's PJP Position: Q4 2015 in Review

Atherton Lane Advisers held its Invesco Pharmaceuticals ETF (PJP) position steady in Q4 2015 at 3,210 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #210.

Atherton Lane Advisers first reported a position in PJP in Q3 2014 and has held it in 6 quarters since. The position peaked at $251K in Q2 2015. 112 funds tracked by Wall St. Rank hold PJP as of Q4 2015.

Atherton Lane Advisers held 3,210 shares of Invesco Pharmaceuticals ETF worth $225K as of Q4 2015.
Atherton Lane Advisers left its Invesco Pharmaceuticals ETF share count unchanged in Q4 2015.
Invesco Pharmaceuticals ETF made up 0.01% of Atherton Lane Advisers's portfolio in Q4 2015, its #210 holding.
Atherton Lane Advisers first reported a position in Invesco Pharmaceuticals ETF in Q3 2014 and has held it in 6 quarters since.
Atherton Lane Advisers's Invesco Pharmaceuticals ETF position peaked at $251K in Q2 2015.
112 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.